Skip to content

Establishment and application of chronic graft-versus-host disease prediction model

Establishment and application of chronic graft-versus-host disease prediction model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102057
Enrollment
Unknown
Registered
2025-05-08
Start date
2025-05-09
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic graft-versus-host disease

Interventions

Gold Standard:The diagnostic criteria of chronic graft-versus-host disease refer to the Chinese expert consensus on the diagnosis and treatment of chronic graft-versus-host disease (2024).
Index test:Prediction model of chronic graft-versus-host disease

Sponsors

The Second Affiliated Hospital of Army Medical University (Xinqiao Hospital of Army Medical University )
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (a) Age >= 18 years old, <=70 years old, both male and female; A suitable donor for allogeneic transplantation; (b) The underlying disease was stable, no progression and no recurrence; (c) Patients or guardians who are willing and able to provide informed consent; (d) Women with reproductive potential are willing to use contraception; (e) Willingness to comply with research programmes and research requirements.

Exclusion criteria

Exclusion criteria: (a) Progression or recurrence of underlying diseases; (b) Complicated with other malignant tumors and undergoing treatment; (c) Infusion of donor lymphocytes or Car-T cells within the last 30 days; (d) Active infection, invasive fungal or viral infection, ineffective against fungal or antiviral therapy.

Design outcomes

Primary

MeasureTime frame
Specific biomarkers ( including : chemokine family, interleukin family, cell subsets, etc. );

Countries

China

Contacts

Public ContactZhang Xi

Medical Center of Hematology, Xinqiao Hospital of Army Medical University

zhangxxi@sina.com+86 23 6876 3198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026